Effect of Hot Flushes on Vascular Function: A Randomized Controlled Trial

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Obstetrics and Gynecology

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AOG.0b013e3181b6f268PMID 19888035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis

  2009cited by this paper
• Evidence for a Role of Hot Flushes in Vascular Function in Recently Postmenopausal Women

  2009cited by this paper
• Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?

  2008cited by this paper
• Hot Flashes and Subclinical Cardiovascular Disease: Findings From the Study of Women’s Health Across the Nation Heart Study

  2008cited by this paper
• Postmenopausal Hormone Therapy and Cardiovascular Disease in Perspective

  2008cited by this paper
• Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation.

  2008cited by this paper
• Menopausal Complaints Are Associated With Cardiovascular Risk Factors

  2008cited by this paper
• SEX HORMONES AND THE CARDIOVASCULAR SYSTEM: EFFECTS ON ARTERIAL FUNCTION IN WOMEN

  2007cited by this paper
• Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief

  2007cited by this paper
• HRT and the young at heart.

  2007cited by this paper
• Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.

  2007cited by this paper
• New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation

  2007cited by this paper
• Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease

  2007cited by this paper
• Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages

  2007cited by this paper
• Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.

  2006cited by this paper
• Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women.

  2006cited by this paper
• Arterial aging: is it an immutable cardiovascular risk factor?

  2005cited by this paper
• An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry

  2005cited by this paper
• Pulse Wave Reflection in Currently and Previously Preeclamptic Women

  2005cited by this paper
• Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy.

  2005cited by this paper
• Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.

  2005cited by this paper
• Effects of hormone therapyon C-reactive protein and IL-6 in postmenopausal women: a review article

  2005cited by this paper
• Pathophysiology and treatment of menopausal hot flashes.

  2005cited by this paper
• Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma.

  2004cited by this paper
• MPA and postmenopausal coronary artery atherosclerosis revisited.

  2003cited by this paper
• Estrogen plus progestin and the risk of coronary heart disease.

  2003cited by this paper
• Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses

  2003cited by this paper
• Increased Levels of C-Reactive Protein After Oral Hormone Replacement Therapy May Not Be Related to an Increased Inflammatory Response

  2003cited by this paper
• Assessment of arterial stiffness in clinical practice.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Transdermal Estradiol in Menopausal Women Depresses Interleukin-6 without Affecting Other Markers of Immune Response

  2002cited by this paper
• Effect of Medroxyprogesterone Acetate on Vascular Inflammatory Markers in Postmenopausal Women Receiving Estrogen

  2002cited by this paper
• Pulse‐Wave Analysis: Clinical Evaluation of a Noninvasive, Widely Applicable Method for Assessing Endothelial Function

  2002cited by this paper
• Assessment of endothelial function using peripheral waveform analysis: a clinical application.

  2002cited by this paper
• Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo.

  2002cited by this paper
• Heart rate dependency of pulse pressure amplification and arterial stiffness.

  2002cited by this paper
• Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

  2002cited by this paper
• Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.

  2002cited by this paper
• Methodologic lessons learned from hot flash studies.

  2001cited by this paper
• Initial 17β‐Estradiol Dose for Treating Vasomotor Symptoms

  2000cited by this paper
• A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease

  2000cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper

• Risk and possibilities of preventing cardiovascular diseases in women in peri- and postmenopause

  2019cites this paper
• Sex-Specific Physiology and Cardiovascular Disease.

  2018cites this paper
• New evidence for cardiac benefit of postmenopausal hormone therapy

  2017cites this paper
• Vasomotor hot flashes and cardiac repolarization: a randomized placebo-controlled trial of postmenopausal hormone therapy

  2017cites this paper
• Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?

  2017cites this paper
• Chinese Obstetrics & Gynecology journal club: a randomised controlled trial

  2016cites this paper
• Cardiac repolarization in recently postmenopausal women with or without hot flushes

  2016cites this paper
• Vaginal estradiol use and the risk for cardiovascular mortality.

  2016cites this paper
• Cardiovascular risk assessment in women – an update

  2016cites this paper
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

  2015cites this paper
• Postmenopausal hot flushes and bone mineral density: a longitudinal study

  2015cites this paper
• Coronary Heart Disease Mortality and Hormone Therapy Before and After the Women's Health Initiative

  2014influential citation
• Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women

  2014cites this paper
• Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy

  2014cites this paper
• Effects of postmenopausal hot flushes and hormone therapy on quality of life and cardiovascular autonomic function

  2014cites this paper
• Reporting of analyses from randomized controlled trials with multiple arms: a systematic review

  2013cites this paper
• Menopausal hot flushes do not associate with changes in heart rate variability in controlled testing: a randomized trial on hormone therapy

  2013influential citation
• Management of Estrogen Deficiency

  2013cites this paper
• Are All Estrogens Created Equal? A Review of Oral vs. Transdermal Therapy

  2012cites this paper
• Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy

  2012cites this paper
• Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

  2012cites this paper
• Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: potential role of estrogen receptor polymorphisms.

  2012cites this paper
• Menopausal hot flashes and insulin resistance

  2012cites this paper
• Effect of hot flushes on cardiovascular autonomic responsiveness: a randomized controlled trial on hormone therapy.

  2012cites this paper
• Menopausal hot flushes and vascular health

  2011cites this paper
• Update in hormone therapy use in menopause.

  2011cites this paper
• AACE Guidelines

  2011cites this paper
• Cardiovascular autonomic responsiveness in postmenopausal women with and without hot flushes.

  2011cites this paper
• Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors

  2011cites this paper
• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause.

  2011cites this paper
• Effect of aerobic training on hot flushes and quality of life—a randomized controlled trial

  2011cites this paper
• Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy

  2010cites this paper
• Estradiol gel 0.1% relieves vasomotor symptoms independent of age, ovarian status, or uterine status

  2010cites this paper
• Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy

  2010cites this paper
• Snippets.

  2009cites this paper